Hester Biosciences Ltd Share Price

₹1574.95 -22.05 (-1.38%) BSE
as updated on 24-Dec-2025 16:59 | Sector - Healthcare

Day Range

  • Day's Low:1570.00
  • Day's High:1590.00

  • 52 Week Low1246.75
  • 52 Week High2489.65

Hester Biosciences Ltd's key Fundamentals

Market Cap ₹1,359 Cr.
P/E Ratio 46.7
TTM EPS 34.2
P/B Ratio 3.90
ROE 9.68
Debt to Equity 0.31
Face Value 10
BVPS 409.1
3 Year Sales Growth 9.31%

Hester Biosciences Ltd's Share Price Returns

1 Day -1.38%
1 Week -0.90%
1 Month -3.20%
3 Months -18.70%
6 Months -14.10%
1 Years -34.20%
3 Years -10.70%
5 Years -8.10%
10 Years 0%

Financial Ratio Analysis

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

Check our DeciZen before investing

Check Stock Quality
Check Stock Valuation
Check Price Trend

Hester Biosciences Ltd Shareholding Pattern

Promoters

(53.73%)

Institutions

(0.53%)

Non-Institutions

(45.74%)

Pledged shares as % of Promoter's holding (%)

(0.00%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Balance Sheet

(All Figures are in Crores.)

Profit And Loss

(All Figures in Cr. Adjusted EPS in Rs.)

Cash Flow

(All Figures are in Crores.)

About Hester Biosciences Ltd

Hester Biosciences was incorporated on April 29, 1987 as a Private Limited Company by the name of Hester Pharmaceuticals Limited. It was subsequently converted into a Public Limited Company on November 1, 1993. The company is engaged in the manufacturing of poultry vaccines. The company has been promoted by Rajiv D. Gandhi his brother Sanjiv D. Gandhi and Dr. Bhupendra V. Gandhi. The company changed its name to the present in 2008.

The company is a 100% biotech company producing animal biologicals. Located near the city of Ahmedabad, in the state of Gujarat, in Western India, Hester has a state-of-the-art facility to produce live and killed (Inactivated) veterinary vaccines.

Production procedures for poultry vaccines based on in-house advanced capabilities are being followed in the areas of virus propagation in specific pathogen-free embryos, tissue culture, batch fermentation of bacteria, lyophilisation and emulsion preparation.

Hester on December 22, 2008 launched a poultry vaccine against Coryza disease in chicken, containing 3 serotypes – A, B & C.

Hester is the first company in India to manufacture the Coryza vaccine with 3 strains as against other companies manufacturing the vaccine with only 2 serotypes - A & C. Coryza disease is of economical importance to poultry farmers as it causes a drop in egg production in laying birds.

Hester currently manufactures 39 types of poultry vaccines against various poultry diseases.

Product range of the company includes:

  • Live Vaccines
  • Killed Vaccines
  • Diagnostic kits &  Seromonitoring services

Achievements/ recognition:

  • GMP and ISO 9001:2000 certified company
Read More Read Less
Read More Read Less

Investment related blogs

Day Range

  • Day's Low: 1570.00
  • Day's High: 1590.00

  • 52 Week Low1246.75
  • 52 Week High2489.65

Hester Biosciences Ltd's key Fundamentals

Market Cap ₹1,359 Cr.
P/E Ratio 46.7
TTM EPS 34.2
P/B Ratio 3.90
ROE 9.68
Debt to Equity 0.31
Face Value 10
BVPS 409.1
3 Year Sales Growth 9.31%

Hester Biosciences Ltd's Share Price Returns

1 Day -1.38%
1 Week -0.90%
1 Month -3.20%
3 Months -18.70%
6 Months -14.10%
1 Years -34.20%
3 Years -10.70%
5 Years -8.10%
10 Years 0%

Investment related blogs

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×